Eciliv Tablet
Eciliv Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL23056106T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- JETPHARMA SDN. BHD.
- Manufacturer
- PHARM PRODUCTS PVT LTD
- Importer
- JETPHARMA SDN. BHD.
- Registration date
- 2023-05-16
- Published validity end
- 2028-05-16
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Eclipta alba | Eclipta alba[52.50 mg,225.00 mg] | Not identified |
| Wedelia calendulacea | Wedelia calendulacea[10.50 mg,225.00 mg] | Not identified |
| Phyllanthus niruri | Phyllanthus niruri[5.25 mg,225.00 mg] | Not identified |
| Tribulus terrestris | Tribulus terrestris[7.50 mg,225.00 mg] | Not identified |
| Glycyrrhiza glabra | Glycyrrhiza glabra[10.50 mg,225.00 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Eclipta alba[52.50 mg,225.00 mg],Wedelia calendulacea[10.50 mg,225.00 mg],Phyllanthus niruri[5.25 mg,225.00 mg],Tribulus terrestris[7.50 mg,225.00 mg],Glycyrrhiza glabra[10.50 mg,225.00 mg]
- Valid until
- 2028-05-16
- Registration date
- 2023-05-16
- Published description
- NATURAL PRODUCT
- Licence holder
- JETPHARMA SDN. BHD.
- Importer
- JETPHARMA SDN. BHD.
- Producer
- PHARM PRODUCTS PVT LTD
- Published name
- Eciliv Tablet
- Published reference
- 202209298999T
- Registration number
- MAL23056106T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL23056106T
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.